Corcept Therapeutics | CORT - 销售收入

股票价格
41.91
每天变化
-0.34 -0.80%
每月一次
24.21%
每年
-38.92%
Q2 预测
40.77


金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 4.47B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


销售 更改 日
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Assertio Holdings USD 29.2M 1.92M 2024-09
Aurora Cannabis CAD 94.19M 3.82M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
J&J USD 24.6B 610M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.86B 50M 2025-12
Novartis USD 13.86B 498M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12